Abu Dhabi, Bayer to explore desert crop trials and wider access to advanced therapies
Dubai: Abu Dhabi Investment Office and Bayer will explore cooperation on desert crop trials, advanced therapies and healthcare access under a new agreement aimed at expanding work across life sciences and food security. Sign up for our daily business newsletter, Cheques & Balances The Memorandum of Understanding creates a framework for ADIO and Bayer to identify projects across health,…
The Abu Dhabi Investment Office (ADIO) and Bayer have signed a Memorandum of Understanding (MoU) to explore cooperation in various areas of life sciences and food security. This includes desert crop trials, advanced therapies, and healthcare access. The goal is to expand work across these sectors and strengthen the emirate's research and innovation ecosystem.
One of the key focus areas is potential field trials to understand how crops perform in desert and arid conditions, which could support food security initiatives in the UAE. The collaboration will also cover healthcare innovation and access to advanced therapies, as well as philanthropic initiatives related to health and food security.
This agreement was signed during the State Visit of Sheikh Mohamed bin Zayed Al Nahyan, President of the UAE, to Germany.
Written by urgent.news from Gulf News's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
